Century Therapeutics (IPSC) Debt Ratio (2020 - 2026)

Century Therapeutics (IPSC) has reported Debt Ratio for 6 consecutive years, with 0.01 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio changed N/A year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (changed N/A YoY), while the FY2025 annual figure was 0.02, changed N/A from the prior year.
• Debt Ratio slipped to 0.01 in Q1 2026 per IPSC's latest filing, from 0.02 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.03 in Q3 2025 and bottomed at 0.01 in Q1 2026.
• Historically, Debt Ratio has averaged 0.02 across 4 years, with a median of 0.02 in 2022.
• Annual changes were most pronounced in 2022 — Debt Ratio decreased 7.4% — and 2023, when it gained 23.98%.
• Century Therapeutics' Debt Ratio stood at 0.02 in 2022, then gained by 7.23% to 0.02 in 2023, then decreased by 25.59% to 0.02 in 2025, then plunged by 64.64% to 0.01 in 2026.
• Business Quant data shows IPSC's Debt Ratio at 0.01 in Q1 2026, 0.02 in Q4 2025, and 0.03 in Q3 2025.